Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19

Go back to Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19
(NASDAQ: TSHA) Delayed: 6.53 -0.12 (1.8%)
Previous Close $6.65    52 Week High
Open $6.70    52 Week Low
Day High $6.81    P/E N/A 
Day Low $6.40    EPS
Volume 2,325,513       

(NASDAQ: TSHA) Delayed: 6.53 -0.12 (1.8%)
Previous Close $6.65    52 Week High
Open $6.70    52 Week Low
Day High $6.81    P/E N/A 
Day Low $6.40    EPS
Volume 2,325,513